2:1 Split: IT Stock Clicks 5% Upper Circuit On Filing Patent For AI-Powered Health Monitoring System

With the filing titled "System for Automated Health Data Collection and Analysis," which corresponds to the application number E-106/2084/2025/CHE, Blue Cloud Softech Solutions Limited (BCSSL) has integrated artificial intelligence (AI) with biosensors for self-health monitoring. This advancement highlights the commitment of BCSSL towards improving healthcare services through technology. BCSSL surely took another leap in the field of healthcare tech with the recent filing of the intellectual property of the patent.

The most differentiating feature of the system is the amalgamation of wearable biosensors with real-time AI-powered analytics. The wearables continuously monitor vital signs like heart rate, glucose levels, breathing rate, etc. These devices with biosensors also contain a form of energy harvesting technology to improve the battery lifespan of the product while providing the necessary energy. The AI engine utilizes Deep Learning models including Convolutional Neural Networks (CNN) and Long Short-Term Memory (LSTM) networks to analyze the data in real-time and provide insights or report abnormal detection.

One very important aspect of the system is the ability to provide real-time alerts to users, caregivers, and healthcare providers concerning possible health threats. The system also strives to enhance data safety and compliance by incorporating encryption and blockchain technology for sensitive health information. This feature together with the provision of accurate continuous health data enables predictive diagnostics as well as proactive personalized health recommendations, which promotes effective self-management of health by individuals

The projected impact of the system on healthcare remains to be seen but its real-time surveillance capability has great potential for chronic disease management and telehealth services, especially for remote and underserved regions. In addition, the ability to derive insights on the health status of entire populations makes it useful in the public health and epidemiology domain for timely intervention during health crises. Its interoperability with electronic health records (EHR) and telemedicine systems improves the quality and access to healthcare services.

BCSSL'S quick adoption into the market is notable due to the firm's strong economic results. The firm recorded net sales of Rs 235.27 crores in Q3 FY25, a net profit of Rs 9.4 crores which is a 131% increase compared to Q3 FY24. For nine months ending December 2024, net sales were Rs 613.24 crores marking an increase of 112%. Net profit for the firm for the same period was Rs 31.23 which marked a staggering 316% increase from the same period in FY24.

Apart from increasing profit margins, BCSSL has recently undertaken a stock split of 2:1, splitting their shares of equity at a face value of Rs 2 into two shares at a face value of Rs 1 each. The stock split record date is set for January 20, 2025. Currently, the company boasts a market capitalization of over Rs 800 crore, along with a stock price CAGR of 50% over the past three years. BCSSL recently filed a patent that will aid the company in furthering its innovation in AI-powered healthcare technology and solidifying its position alongside other leading companies in the field BCSSL is a frontrunner in building stimulus for the AIIoT (Artificial Intelligence of Things) Industry in India and along with providing AI based healthcare products and technology, they encourage technological progress, enabling transformation across various businesses and communities.

These changes are done to enhance their contribution across these various platforms while also bringing forth locally designed and efficient high performance solutions.